Interest rates are up. Should you be worried?

Interest rates are up. Should you be worried?

Up next

Will Anthropic's IPO go boom or bust?

In the few years since its inception, Anthropic has become one of the buzziest companies in tech. In their own words, they’re an AI enterprise that “puts safety at the frontier”. And this week they’re one step closer to going public with one of the biggest initial public offering ...  Show more

US Politics! Will Texas flip, who's bailing on Trump?

On Tuesday, Americans will go to the polls in a midterm vote that stands to challenge the Republican hold on both chambers of congress. For the first time in decades, a state like Texas may flip from Republican to Democrat. The implications would be vast for a Trump administratio ...  Show more

Recommended Episodes

Halted: Johnson & Johnson & the Vaccination Timeline
Squawk Pod

After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ...  Show more

Coronavirus: How Scary Are the Variants?
Science Vs

UPDATE 4/13/21: Since this episode published, there has been some evidence linking the Johnson & Johnson coronavirus vaccine to rare blood clots. As of April 13, there were six cases in the U.S. out of more than 6.8 million doses, and one person had died. The CDC and FDA have rec ...  Show more

Are all viral vector vaccines a problem?
What's That Rash?

American health regulators have paused the use of the Johnson & Johnson coronavirus vaccine, following reports of rare blood clotting in six recipients. Like the AstraZeneca vaccine, Johnson & Johnson is what's known as a viral vector vaccine - where another virus is used like a ...  Show more